Mäkelä A L, Peltola O, Mäkelä P
Scand J Rheumatol. 1978;7(3):161-5. doi: 10.3109/03009747809095647.
Serum gold levels were monitored in 66 children with juvenile rheumatoid arthritis, treated with different i.m. dosage schedules of sodium aurothiomalate (Myocrisin, Pharma Rhodia). The ages of the children varied from 1 to 15 years. Gold serum levels in children were related to the dose of Myocrisin calculated per kg of body weight or per square metre of body surface area. The results of our study indicate that in order to achieve a peak serum level at about 500--600 microgram/100 ml (25--30 micromol/l) with weekly injections, the dose of Myocrisin should be about 0.7 mg/kg, or 20 mg/m2. In order to avoid excessively high gold serum concentrations, the maximum single dose should not exceed 27 mg/m2 of body surface area.
对66例幼年类风湿性关节炎患儿进行了血清金水平监测,这些患儿接受了不同肌内注射硫代苹果酸金钠(Myocrisin,罗地亚制药公司)剂量方案的治疗。患儿年龄在1至15岁之间。儿童血清金水平与按每千克体重或每平方米体表面积计算的Myocrisin剂量相关。我们的研究结果表明,为了通过每周注射在血清中达到约500 - 600微克/100毫升(25 - 30微摩尔/升)的峰值水平,Myocrisin的剂量应为约0.7毫克/千克或20毫克/平方米。为避免血清金浓度过高,单次最大剂量不应超过体表面积27毫克/平方米。